Seven Bridges Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Seven Bridges Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-14,552	Closed	-$184K	–	156
2017 Q1	$184K	Sell	14,552 -25,631	-64%	-$310K	0.18%	104
2016 Q4	$532K	Buy	40,183 +2,774	+7%	+$47.4K	0.54%	56
2016 Q3	$887K	Buy	37,409 +5,219	+16%	+$140K	0.79%	37
2016 Q2	$928K	Buy	32,190 +108	+0.3%	+$3.52K	0.8%	37
2016 Q1	$1.03M	Buy	32,082 +11,874	+59%	+$417K	0.81%	39
2015 Q4	$864K	Buy	+20,208	New	+$807K	0.87%	38

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Seven Bridges Advisors's IPXL Position: Q2 2017 in Review

Seven Bridges Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 14,552 shares — an estimated $184K sold.

Seven Bridges Advisors first reported a position in IPXL in Q4 2015 and held it in 6 quarters. The position peaked at $1.03M in Q1 2016. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

Seven Bridges Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
Seven Bridges Advisors sold 14,552 Impax Laboratories, Inc. shares in Q2 2017, an estimated $184K.
Seven Bridges Advisors first reported a position in Impax Laboratories, Inc. in Q4 2015 and held it in 6 quarters.
Seven Bridges Advisors's Impax Laboratories, Inc. position peaked at $1.03M in Q1 2016.
172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Seven Bridges Advisors's 13F filing for Q2 2017, filed 1 Aug 2017.